Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertumaxomab in HER2+ solid tumors
NCT01569412Phase 2Terminated
- Sponsor
- Krankenhaus Nordwest
- Start
- Mar 2012
- Primary completion
- May 2016
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ertumaxomab in solid tumor, sponsored by Krankenhaus Nordwest. Started Mar 2012; status: terminated.
02
Drugs
ertumaxomab
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT01569412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569412.